 SAN DIEGO, Dec. 11, 2020 PRNewswire -- Arena Pharmaceuticals, Inc. Nasdaq: ARNA today announced that data from the Phase 2b ADVISE trial evaluating the safety and efficacy of etrasimod, a highly selective, once-daily, oral sphingosine 1-phosphate S1P receptor modulator, in... 